Aristopharma Ltd

News

 

Aristopharma has launched Apetiz 100 ml Oral Suspension.

Apetiz is indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss. It is also indicated for the palliative treatment of advanced carcinoma of the breast (i.e. recurrent, inoperable or metastatic diseases). Apetiz Suspension is a powerful appetite stimulant and can be considered as an antiemetic option for chemotherapy. It is manufactured with US DMF certified raw material which ensures the quality, safety and efficacy of the product. Apetiz Suspension is lemon flavored, tasty suspension- patients would love to take it.